Research indicates that APOE4 allele correction can improve cholesterol metabolism and Aβ clearance dysfunction in APOE4-carrying astrocytes, validated in AD models and potentially applicable to post-TBI neurodegeneration treatment (329). Here, APOE is linked to Alzheimer disease.